Insider Transactions in Q2 2022 at Black Diamond Therapeutics, Inc. (BDTX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jun 29 2022	Fang Ni	BUY Open market or private purchase	Direct	25,000 +26.59%	$50,000 $2.44 P/Share
Jun 17 2022	Robert Alexander Ingram	BUY Grant, award, or other acquisition	Direct	8,498 +24.01%	$16,996 $2.03 P/Share
Jun 17 2022	Wendy L Dixon	BUY Grant, award, or other acquisition	Direct	4,060 +50.0%	$8,120 $2.03 P/Share
Jun 17 2022	Mark A. Velleca PRESIDENT & CEO	BUY Grant, award, or other acquisition	Direct	5,542 +39.64%	$11,084 $2.03 P/Share
Jun 17 2022	Ali Behbahani	BUY Grant, award, or other acquisition	Direct	5,850 +27.33%	$11,700 $2.03 P/Share
Apr 28 2022	Growth N V Biotech	BUY Open market or private purchase	Direct	255,711 +5.17%	$511,422 $2.57 P/Share
Apr 27 2022	Growth N V Biotech	BUY Open market or private purchase	Direct	150,000 +3.27%	$300,000 $2.66 P/Share
Apr 19 2022	Growth N V Biotech	BUY Open market or private purchase	Direct	150,000 +3.38%	$450,000 $3.24 P/Share
Apr 18 2022	Growth N V Biotech	BUY Open market or private purchase	Direct	150,000 +3.5%	$450,000 $3.29 P/Share
Apr 13 2022	Growth N V Biotech	BUY Open market or private purchase	Direct	102,556 +2.51%	$307,668 $3.57 P/Share
Apr 12 2022	Growth N V Biotech	BUY Open market or private purchase	Direct	150,000 +3.72%	$450,000 $3.42 P/Share

Receive a notification when an Institution or Guru buys or sells BDTX shares.

Notify only if

Value

Get notified when an Black Diamond Therapeutics, Inc. insider buys or sells BDTX shares.

Notify only if

Operation

Value

Type

Receive news related to Black Diamond Therapeutics, Inc.